metformin has been researched along with Familial Primary Pulmonary Hypertension in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Familial Primary Pulmonary Hypertension: Familial or idiopathic hypertension in the PULMONARY CIRCULATION which is not secondary to other disease.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goncharov, DA | 1 |
Goncharova, EA | 1 |
Tofovic, SP | 1 |
Hu, J | 1 |
Baust, JJ | 1 |
Pena, AZ | 1 |
Ray, A | 1 |
Rode, A | 1 |
Vanderpool, RR | 1 |
Mora, AL | 1 |
Gladwin, MT | 1 |
Lai, YC | 1 |
1 other study available for metformin and Familial Primary Pulmonary Hypertension
Article | Year |
---|---|
Metformin Therapy for Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction versus Pulmonary Arterial Hypertension.
Topics: Animals; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Heart Failure; Hypertensio | 2018 |